Global Blood Therapeutics

$40.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-1.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GBT and other stocks, options, and ETFs commission-free!

About GBT

Global Blood Therapeutics, Inc. Common Stock, also called Global Blood Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders.

CEO
Ted W. Love
Employees
389
Headquarters
South San Francisco, California
Founded
2011
Market Cap
2.61B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
827.35K
High Today
$41.57
Low Today
$40.22
Open Price
$41.01
Volume
976.47K
52 Week High
$83.69
52 Week Low
$36.49

GBT Earnings

-$1.59
-$1.06
-$0.53
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

BKU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure